-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Navidea Biopharmaceuticals, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2011 to Q1 2023.
- Navidea Biopharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2023 was $27.6K, a 20.4% increase year-over-year.
- Navidea Biopharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $48.2K, a 31% increase from 2021.
- Navidea Biopharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2021 was $36.8K, a 8.47% increase from 2020.
- Navidea Biopharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2020 was $33.9K, a 67.1% decline from 2019.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)